Bempedoic Acid Pregnancy Surveillance Program

Description

Bempedoic acid pregnancy surveillance program

Conditions

Pregnancy, Hyperlipidemias

Talk to us

Study Overview

On this page

Study Details

Study overview

Bempedoic acid pregnancy surveillance program

A Post-marketing, Long-term, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Women Exposed to Bempedoic Acid or Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) During Pregnancy

Bempedoic Acid Pregnancy Surveillance Program

Condition
Pregnancy
Intervention / Treatment

-

Contacts and Locations

Morrisville

Evidera, PPD business unit, Morrisville, North Carolina, United States, 27560

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    FEMALE

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    Esperion Therapeutics, Inc.,

    Christine Broestl, MS, STUDY_DIRECTOR, Esperion Therapuetics

    Study Record Dates

    2032-05